Jingjing Chen - Publications

DNA demethylation of ANXA4 is associated with atrial fibrillation risk through myeloid immune mechanisms: evidence from Mendelian randomization and multi-omics analyses.

Journal: Clinical epigenetics

Published: December 10, 2025

Outcomes of simplified left atrial appendage occlusion using the WATCHMAN FLX device: the ROSE-FLX study.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: December 10, 2025

HNRNPA2B1: a novel target in pulmonary arterial hypertension.

Journal: Frontiers in cardiovascular medicine

Published: September 21, 2024

Impact of age-related gut microbiota dysbiosis and reduced short-chain fatty acids on the autonomic nervous system and atrial fibrillation in rats.

Journal: Frontiers in cardiovascular medicine

Published: March 02, 2024

Characterization of skin sympathetic nerve activity in patients undergoing ablation of ventricular tachycardia.

Journal: Heart rhythm

Published: January 30, 2024

Predictive value of serum lncRNA MALAT1 for the recurrence of persistent atrial fibrillation after radiofrequency ablation.

Journal: Biomarkers in medicine

Published: July 25, 2023

Trimethylamine N-oxide promotes abdominal aortic aneurysm by inducing vascular inflammation and vascular smooth muscle cell phenotypic switching.

Journal: European journal of pharmacology

Published: July 23, 2023

Relationship between left atrial appendage peak flow velocity and nonvalvular atrial fibrillation recurrence after cryoablation.

Journal: Frontiers in cardiovascular medicine

Published: September 25, 2022

3-iodothyronamine inhibits apoptosis induced by myocardial ischemia reperfusion via the Akt/FoxO1 signaling pathway.

Journal: Annals of translational medicine

Published: December 07, 2021

MicroRNA-23b prevents aortic aneurysm formation by inhibiting smooth muscle cell phenotypic switching via FoxO4 suppression.

Journal: Life sciences

Published: August 03, 2020

Exendin-4 inhibits atrial arrhythmogenesis in a model of myocardial infarction-induced heart failure via the GLP-1 receptor signaling pathway.

Journal: Experimental and therapeutic medicine

Published: March 19, 2020

Exendin-4 Reduces Ventricular Arrhythmia Activity and Calcium Sparks-Mediated Sarcoplasmic Reticulum Ca Leak in Rats with Heart Failure.

Journal: International heart journal

Published: January 21, 2020